John F. Crowley is the President and CEO of the Biotechnology Innovation Organization (BIO), the world’s largest biotechnology advocacy organization. Crowley, a longtime BIO board member, was most recently the Founder and Executive Chairman of Amicus Therapeutics, a global biotechnology company focusing on developing treatments for rare genetic diseases. He served as Chief Executive Officer of Amicus from 2005 to 2022.

John’s decades of biotech experience and deep passion for the field have made him a strong supporter of policies that empower innovation, enable entrepreneurship, and put people and patients first. His involvement with biotechnology stems from the 1998 diagnosis of two of his children with Pompe disease—a severe and often fatal neuromuscular disorder.

John and his family have been profiled numerous times by The Wall Street Journal. The 2010 major motion picture, Extraordinary Measures, starring Brendan Fraser, Harrison Ford, and Keri Russell, is inspired by the Crowley family journey. John also served as a commissioned officer in the U.S. Navy Reserve from 2005-2016. He is a veteran of the global war on terrorism, and his assignments included service with the Joint Special Operations Command (JSOC), the Naval Special Warfare Development Group (NSWDG), and the Central Intelligence Agency (CIA).